Vestal Point Capital, LP Uni Qure N.V. Transaction History
Vestal Point Capital, LP
- $1.9 Trillion
- Q2 2025
A detailed history of Vestal Point Capital, LP transactions in Uni Qure N.V. stock. As of the latest transaction made, Vestal Point Capital, LP holds 3,700,000 shares of QURE stock, worth $61 Million. This represents 2.72% of its overall portfolio holdings.
Number of Shares
3,700,000
Previous 4,792,572
22.8%
Holding current value
$61 Million
Previous $50.8 Billion
1.53%
% of portfolio
2.72%
Previous 3.63%
Shares
6 transactions
Others Institutions Holding QURE
# of Institutions
184Shares Held
51.7MCall Options Held
4.43MPut Options Held
1.27M-
Rtw Investments, LP New York, NY5.16MShares$85.1 Million1.1% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.99MShares$65.8 Million4.79% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.63MShares$59.8 Million0.92% of portfolio
-
Abrdn PLC2.75MShares$45.4 Million0.07% of portfolio
-
Jefferies Financial Group Inc. New York, NY2.1MShares$34.6 Million0.26% of portfolio
About uniQure N.V.
- Ticker QURE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,729,100
- Market Cap $771M
- Description
- uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...